De Vanna M - Search Results

1

Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia.

Carlino D, Leone E, Di Cola F, Baj G, Marin R, Dinelli G, Tongiorgi E, De Vanna M. Carlino D, et al. Among authors: de vanna m. J Psychiatr Res. 2011 Feb;45(2):273-9. doi: 10.1016/j.jpsychires.2010.06.012. Epub 2010 Jul 14. J Psychiatr Res. 2011. PMID: 20630543

2

Is altered BDNF biosynthesis a general feature in patients with cognitive dysfunctions?

Carlino D, De Vanna M, Tongiorgi E. Carlino D, et al. Among authors: de vanna m. Neuroscientist. 2013 Aug;19(4):345-53. doi: 10.1177/1073858412469444. Epub 2012 Dec 14. Neuroscientist. 2013. PMID: 23242909 Review.

3

Repeated suicidal behaviour: Stressful life events and 5-HTTLPR genetic polymorphism.

Schillani G, Goljevscek S, Carlino D, De Vanna M, Aguglia E, Giraldi T. Schillani G, et al. Among authors: de vanna m. Int J Psychiatry Clin Pract. 2009;13(3):229-32. doi: 10.1080/13651500902785652. Int J Psychiatry Clin Pract. 2009. PMID: 24916825

4

[Potential benefits and limitations of new technologies in the personalized treatment of depression].

Carlino D, De Vanna M. Carlino D, et al. Among authors: de vanna m. Riv Psichiatr. 2011 May-Jun;46(3):155-71. doi: 10.1708/889.9806. Riv Psichiatr. 2011. PMID: 21779096 Review. Italian.

5

Psychological treatments versus treatment as usual for obsessive compulsive disorder (OCD).

Gava I, Barbui C, Aguglia E, Carlino D, Churchill R, De Vanna M, McGuire HF. Gava I, et al. Among authors: de vanna m. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005333. doi: 10.1002/14651858.CD005333.pub2. Cochrane Database Syst Rev. 2007. PMID: 17443583 Review.

6

Mental adaptation to cancer: depression and blood platelet monoamine oxidase activity in breast cancer patients.

Giraldi T, De Vanna M, Malagoli M, Tuveri G, Sutto K, Schillani G, Grassi L. Giraldi T, et al. Among authors: de vanna m. Anticancer Res. 2007 May-Jun;27(3B):1715-9. Anticancer Res. 2007. PMID: 17595803 Free article.

7

Psychological response to cancer: role of 5-HTTLPR genetic polymorphism of serotonin transporter.

Schillani G, Martinis E, Capozzo MA, Era D, Cristante T, Mustacchi G, Conte MA, DE Vanna M, Grassi L, Giraldi T. Schillani G, et al. Among authors: de vanna m. Anticancer Res. 2010 Sep;30(9):3823-6. Anticancer Res. 2010. PMID: 20944177

8

5-HTTLPR polymorphism of serotonin transporter and effects of sertraline in terminally ill cancer patients: report of eleven cases.

Schillani G, Capozzo MA, Aguglia E, De Vanna M, Grassi L, Conte MA, Giraldi T. Schillani G, et al. Among authors: de vanna m. Tumori. 2008 Jul-Aug;94(4):563-7. doi: 10.1177/030089160809400419. Tumori. 2008. PMID: 18822694

9

Serotonin transporter 5-HTTLPR polymorphism and response to citalopram in terminally ill cancer patients: report of twenty-one cases.

Capozzo MA, Schillani G, Aguglia E, De Vanna M, Grassi L, Conte MA, Giraldi T. Capozzo MA, et al. Among authors: de vanna m. Tumori. 2009 Jul-Aug;95(4):479-83. doi: 10.1177/030089160909500412. Tumori. 2009. PMID: 19856660

10

Pharmacogenetics of escitalopram and mental adaptation to cancer in palliative care: report of 18 cases.

Schillani G, Capozzo MA, Era D, De Vanna M, Grassi L, Conte MA, Giraldi T. Schillani G, et al. Among authors: de vanna m. Tumori. 2011 May-Jun;97(3):358-61. doi: 10.1177/030089161109700317. Tumori. 2011. PMID: 21789016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters